Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
01:35pm, Thursday, 05'th Mar 2026
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) shares are up on Thursday, reflecting a positive market response to a research collaboration agreement with Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY).
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments
09:10am, Thursday, 05'th Mar 2026
Tenaya Therapeutics said on Thursday it has signed a research deal with Alnylam Pharmaceuticals worth up to $1.13 billion to develop treatments for heart diseases.
Agreement Combines Tenaya's Expertise in Identification and Validation of Genetic Heart Disease Targets with Alnylam's Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 Mill
Elo Mutual Pension Insurance Co Purchases 3,738 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
05:02am, Tuesday, 03'rd Mar 2026
Elo Mutual Pension Insurance Co lifted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 26.5% in the third quarter, according to the company in its most recent disclosure with
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
04:07pm, Monday, 02'nd Mar 2026
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Andra AP fonden Increases Stake in Alnylam Pharmaceuticals, Inc. $ALNY
04:40am, Saturday, 28'th Feb 2026
Andra AP fonden raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 200.0% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 20,7
GSK Strikes $1 Billion China RNA Deal
11:43am, Tuesday, 24'th Feb 2026
GSK plc (GSK) is making a calculated bet on next generation gene silencing drugs, signing a licensing agreement worth up to $1 billion with China's Frontier Bio
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
10:00am, Monday, 23'rd Feb 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the TD Cowen
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Lansforsakringar Fondforvaltning AB publ
06:05am, Monday, 23'rd Feb 2026
Lansforsakringar Fondforvaltning AB publ raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 5.4% in the third quarter, according to the company in its most recent disclosure
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
08:30am, Thursday, 19'th Feb 2026
AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology mergers and acquisitions (M&As) are increasingly shaped by a clear strategic evolution. Pharmaceutical com
Alnylam Pharmaceuticals, Inc. $ALNY Shares Purchased by Merit Financial Group LLC
04:48am, Wednesday, 18'th Feb 2026
Merit Financial Group LLC increased its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 123.9% during the undefined quarter, according to its most recent Form 13F filing with the
Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Skandinaviska Enskilda Banken AB publ
04:15am, Wednesday, 18'th Feb 2026
Skandinaviska Enskilda Banken AB publ decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 6.2% in the third quarter, according to its most recent 13F filing with the Securities a
Why Alnylam Pharmaceuticals Stock Was Soaring on Monday
03:27pm, Tuesday, 17'th Feb 2026
Two analysts weighed in with new evaluations of the biotech. This followed last week's earnings release.
Principal Financial Group Inc. Sells 45,114 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
04:50am, Tuesday, 17'th Feb 2026
Principal Financial Group Inc. cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 89.3% during the undefined quarter, according to its most recent filing with the Securities
Aberdeen Group plc Sells 61,228 Shares of Alnylam Pharmaceuticals, Inc. $ALNY
03:16am, Monday, 16'th Feb 2026
Aberdeen Group plc lessened its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 28.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
